Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 56INDUSTRY 10NETWORK 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 30Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 18Lung Neoplasms 14Head and Neck Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Ovarian Neoplasms 7Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Salivary Gland Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms, Male 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1

Interventions

Paclitaxel 9Fluorouracil 9Cisplatin 9Radiotherapy 8Oxaliplatin 6Irinotecan 5Leucovorin 4Docetaxel 4Cetuximab 4Carboplatin 3Taxes 2Surgical Procedures, Operative 2Polymerase Chain Reaction 2Filgrastim 2Capecitabine 2uridine triacetate 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1durvalumab 1carfilzomib 1atezolizumab 1Vorinostat 1Sorafenib 1Radiosurgery 1Psychiatric Rehabilitation 1Preoperative Exercise 1Platinum 1Lithium 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Esophageal Neoplasms × Docetaxel × Clear all
NCT00551759 2023-07-03

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Eastern Cooperative Oncology Group

Phase 2 Terminated
22 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00003864 2023-06-15

Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus

Eastern Cooperative Oncology Group

Phase 2 Completed
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01726452 2022-09-30

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

Cancer Trials Ireland

Phase 3 Completed
377 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01498289 2019-11-07

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

SWOG Cancer Research Network

Phase 2 Completed
213 enrolled 17 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡